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Editorial on the Research Topic
Glia-Mediated Neurotoxicity: Uncovering the Molecular Mechanisms

Glial cells, including non-neuronal cells of the neuroepithelium (oligodendrocytes,
astrocytes, oligodendrocyte progenitor cells, ependymal cells), neural crest (peripheral
glia), and of myeloid origin (microglia), constitute a large fraction of the central nervous
system (CNS). Glia was initially described in 1856 by pathologist Rudolf Virchow as a
“connective tissue” that binds nervous elements together (Parpura et al., 2012). During
the course of the twentieth century, microglia were discovered and neuroscientists’
views evolved toward considering glia only as auxiliary cells of neurons (von Bernhardi
et al., 2016). For decades, glial cells were considered silent partners of CNS neuronal
physiology. Now, it is well accepted that they are crucial players of the nervous system
homeostasis, playing active regulatory role in immune surveillance, buffer the action of
neurotransmitters, and secrete nerve growth factors and cytokines (Hamilton et al., 2007;
Huizinga et al., 2012). In addition, glial cells are able to induce neurogenesis, regulate
neuronal activity and synaptic transmission (Grubisic and Gulbransen, 2017). Gliamediated neurotoxicity due to glia cells dysfunction has been known to play an important
role in a wide range of neurological disorders however, its cellular and molecular
mechanisms have yet to be fully understood. Gaining a greater understanding of gliamediated neurotoxicity will not only provide insight into this critical biological event,
but also be instrumental in advancing knowledge of brain development and neurological
diseases. The current issue provides a platform for a critical review on recent advances
and original articles that offer significant insights into biochemical and molecular aspects
of glia-mediated neurotoxicity with the potential of identifying novel therapeutic targets.
Over the past several decades, a large amount of data revealed that the crosstalk
between glial cells and neurons represents an exceptional feature for maintaining
the normal function of CNS. Recently, extracellular vesicles (EVs) released by both
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glia and neurons were considered to play important roles
in exchanging molecular information between neural cells.
Extracellular vesicles have been shown to contain and transfer
proteins and nucleic acids to target cells, modulating their
functional activity (Koniusz et al., 2016). A review article by
Ahmad et al. shed a new light on the role of extracellular
(EVs) in glia and neuronal cells’ communication and
their roles in CNS physiology and pathology. The authors
demonstrated that different types of glia and neuronal cells
secrete various types of EVs, resulting in specific functions in
intercellular communications.
Among glial cells, astrocytes are the most numerous cells
in the central nervous system (Jakel and Dimou, 2017).
They play a diverse role, regulating neuronal functions,
oligodendroglia differentiation, blood-barrier maintenance, and
homeostasis in the CNS. Astrocytes are engaged in various
physiological processes including brain energy metabolism of
glucose (Duran-Aniotz and Hetz, 2016). In glucose metabolism,
part of glucose used to convert UDP-GlcNAc as a donor
molecule for O-GlcNAcylation is controlled by O-GlcNAc
transferase enzyme (OGT). The role of O-GlcNAcylation
in astrocytes is almost completely unknown. Performing
proteomic analysis of medial prefrontal cortex (mPFC) tissues
obtained from astrocyte specific conditional OGT knockout
mice, the studies presented in this issue by Fan et al.
have shown that astrocytic OGT could alter the expression
of proteins participating in metabolic processes, transferase
activity, and biosynthetic processes. These results paved the
path for further investigation of astrocytic OGT’s role in the
mPFC, which plays a critical role in numerous behavioral and
cognitive functions.
In certain conditions, astrocytes respond to the injury,
infection and inflammation by acquiring reactive astrogliosis,
a pathological hallmark of CNS structural lesions (Sofroniew
and Vinters, 2010). It is reported that microglia activated
by neuro-inflammatory insults induce the conversion of
resting astrocytes to reactive astrocytes secreting TNFα, IL1α, and C1Cq11q (TIC). Thus, reactive astrocytes have
been implicated as a source of various neurotoxic factors
to neurons and oligodendrocytes (Di Giorgio et al., 2007;
Liddelow et al., 2017). In this issue, Labib et al. presented
a human induced pluripotent stem cell (hiPSC) model
to investigate the surface marker profile and proteome
of TIC-induced reactive astrocytes. The authors identified
VCAM1M, BST2T, ICOSL, HLA-E, PD-L1L, and PDPN as
novel markers of TIC-induced reactive astrocytes. Moreover,
proteomic analysis of TIC-induced reactive astrocyte identified
proteins and related pathways linked to engagement with
peripheral immune cells (Labib et al.). These findings have
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potential to serve as new tools to identify reactive astrocyte
subtypes in neurodegenerative diseases and investigate their
involvement in glia-mediated neurotoxicity. Interestingly, the
authors found that several of these markers co-localize with
GFAP+ cells in post-mortem samples from people with
Alzheimer’s disease.
In another paper presented in this issue, Smith et al.
explored the impact of reactive astrocytes on oligodendrocyte
differentiation in a human system using human hiPSCderived astrocytes and a human oligodendrocyte reporter
cell line. The hypothesis underlying these experiments
was to discern whether inherent differences exist in
astrocytes related to multiple sclerosis (MS). They reported
that the pro-inflammatory hiPSC-astrocyte secretome
inhibited hESC-derived oligodendrocyte precursor cell
(OPC) differentiation. Bulk transcriptome analysis of
human OPC-enriched cultures identified significantly
differentially regulated genes and pathways that may
contribute to failed re-myelination phenotype (Smith
et al.). This study adds important new information in
terms of understanding generalizable astrocyte responses
in MS.
In brief, research topic introduced in the special issue
of Frontiers in Molecular Neuroscience highlights the role
of glia-mediated toxicity in neurodegenerative disorders. As
our understanding of glial cell biology grows, so too will the
probability of developing effective therapeutic strategies.
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